Ocular Therapeutix OCUL
NASDAQ OCUL
$6.61 +0.13 (+2.01%)
At close: Oct 22, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Depreciation and Depletion (2013 - 2014)

Updated

Ocular Therapeutix's Depreciation and Depletion was $139,000 in Q3 2014, up 51.1% from $92,000 a year earlier.

Analysis

Ocular Therapeutix (OCUL) Depreciation and Depletion (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 194.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 98.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Ocular Therapeutix 1.45 Bn -895.69 Mn 11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 139,000.00
Sep 30, 2013 92,000.00
API Access

Ocular Therapeutix Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=OCUL&period=max&api_key=YOUR_API_KEY